Chao Tung Wen
Director/Board Member bij TATUNG SYSTEM TECHNOLOGIES INC.
Profiel
Chao Tung Wen is an Independent Director at Tatung System Technologies, Inc. and a Professor at National Chengchi University.
He previously held positions as Chairman at Eastern Ad, and as an Independent Director at E Ink Holdings, Inc. and PharmaDax Inc. Dr. Wen holds an MBA from the University of Rochester, a doctorate from Rensselaer Polytechnic Institute, and an undergraduate degree from Tunghai University.
Actieve functies van Chao Tung Wen
| Bedrijven | Functie | Begin |
|---|---|---|
| TATUNG SYSTEM TECHNOLOGIES INC. | Director/Board Member | 24-06-2013 |
| National Chengchi University | Corporate Officer/Principal | - |
Eerdere bekende functies van Chao Tung Wen
| Bedrijven | Functie | Einde |
|---|---|---|
| E INK HOLDINGS INC. | Director/Board Member | - |
| Eastern Ad | Chairman | - |
| PHARMADAX INC. | Director/Board Member | - |
Opleiding van Chao Tung Wen
| Rochester Christian University | Masters Business Admin |
| Rensselaer Polytechnic Institute | Doctorate Degree |
| Tunghai University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| TATUNG SYSTEM TECHNOLOGIES INC. | Commercial Services |
| E INK HOLDINGS INC. | Electronic Technology |
| Bedrijven in privébezit | 2 |
|---|---|
PharmaDax Inc.
 PharmaDax Inc. Pharmaceuticals: MajorHealth Technology PharmaDax Inc. engages in the development and marketing of generic dossiers. Its products include Glyburide, Quetiapine Fumarate ER, and Metoprolol Succinate ER tablets. The company was founded by Yi Pin Huang on March 21, 2008 and is headquartered in New Taipei, Taiwan. | Health Technology |
| Eastern Ad |
